Hugel, Inc. (United States)

Hugel is a South Korean biopharmaceutical company specializing in botulinum toxin products and aesthetic medicine. The company develops and manufactures Letybo (prabotulinumtoxinA) for cosmetic use in reducing facial wrinkles. Hugel’s expertise in neurotoxins and aesthetics expands treatment options in the medical aesthetics market.